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512a Tuesday, February 28, 20128-(4-chlorophenylthio)-2’-O-methyladenosine-3’, 5’-cyclic monophosphate
(cpTOME), an analogue of cAMP. Simultaneous measurements of intracellular
calcium ([Ca2þ]i) with Fura-2 and isometric force were made in RV trabeculae
before and during cpTOME application. At 1.5 mM [Ca2þ]o, 10 mM cpTOME
had no effect on the amplitude of [Ca2þ]i transients (0.7 5 0.1 to 0.7 5 0.1,
P ¼ 0.35) or on twitch force (24.1 5 5.2 mN mm2 to 22.80 5 4.62 mN
mm2, P ¼ 0.20) (n = 7). However, at 0.5 mM [Ca2þ]o, cpTOME increased
peak stress from 10.5 5 2.8 mN mm2 to 15.0 5 2.7 mN mm2, P = 0.01
(n = 6), but without any change in [Ca2þ]i transients (P = 0.16). The force-
[Ca2þ]i relationship of intact trabeculae exhibited increased myofilament Ca
2þ
sensitivity with cpTOME at low [Ca2þ]o but not at 1.5 mM [Ca
2þ]o. In isolated
cells, cpTOME increased Ca2þ spark frequency (Fluo-4) from 6.6 per 100 mm3
s (n = 3) to 32.3 per 100 mm3 s (n = 9), P = 0.05, with a reduction in the peak am-
plitude of the sparks. The latter result recapitulates the idea that changes in RyR
sensitivity do not alter the amplitude of Ca2þ transients (Eisner, 2009).
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Ras related proteins regulate the activity of the serine-threonine protein kinase
Pak1, which has been implicated in the regulation of cytoskeletal dynamics and
motility. Recent evidence points to its role in cardiac ECC by attenuation of the
b-adrenergic stimulation of ICa,L and IKr through activation of the phospha-
tase PP2A. To further determine the role of Pak1 in cardiac ECC we analyzed
the Ca handling properties of isolated ventricular myocytes (VM) from Pak1-/-
mice by laser scanning confocal microscopy. Isolated VMs from Pak1-/- mice
exhibited a reduced Ca transient amplitude (D F/F0 WT: 1.78 5 0.22 n=10;
Pak1-/-: 1.26 5 0.18 n=7, p<0.05) that was not based on a decrease in the
load of the sarcoplasmic reticulum (WT: 5.58 5 0.32; Pak1-/-: 4.82 5 0.31)
or a decrease in the current density of ICa,L (@-10mV: WT: 4.15 0.5 n=11
pA/pF; Pak1-/-: 4.025 1.6 n=9). However, the rise time of the Ca transient
in Pak1-/- myocytes was significantly delayed (WT: 79 5 5 ms; Pak1-/-:
119 5 7 ms, p<0.05). The reduced amplitude could be based on a modified
gain between Ca influx and Ca induced Ca release through the ryanodine recep-
tor. b-adrenergic stimulation with isoproterenol (100 nM) not only rescued the
Ca transient rise time in Pak1-/- myocytes but induced an exaggerated increase
in Ca-transient amplitude (F/F0: WT: 4.4550.25; Pak1-/-: 5.2250.26;
p<0.05) and decrease in tau (WT: 159.858ms; Pak1-/-: 12153ms;
p<0.05). The direct involvement of Pak1 in this process is suggested by the re-
versal of all parameters to control conditions by adenoviral overexpression of
Pak1 in Pak1-/- VMs. Our results further support the role of Pak1 as a modulator
of b-adrenergic stimulation in VMs and indicate a novel role in the mainte-
nance of cardiac ECC gain.
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Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by se-
vere muscle wasting. Dystrophic muscles exhibit activated immune cell infil-
trates with up-regulated inflammatory gene expression and increased NF-kB
activity, but the contribution of the skeletal muscle cell to this process has
been unclear. The aim of this work was to study the resting calcium [Ca2þ]
rest deregulation and its possible link with NF-kB up-regulation and iNOS ex-
pression in mdx myotubes.
[Ca2þ]rest was measured with Ca2þ-selective microelectrodes and NF-kB
transcriptional activity was studied using luciferase reporter and immunofluo-
rescence in wt and mdx myotubes. Gene expression was studied by real time
PCR.
[Ca2þ]rest was higher in mdx than in wt myotubes (30856 vs 11352 nM,
p<0.001). Both the inhibition of Ca2þ entry (Gd3þ and low Ca2þ solutions)
and blockade of ryanodine (Ry) receptors or IP3 receptors (XeB), reduced
[Ca2þ]rest in mdx myotubes. Basal activity of NF-kB was significantly up-
regulated in mdx myotubes. This was shown by an increased p65 nuclear local-
ization and increased transcriptional activity, which could be reversed by
inhibitors that reduced [Ca2þ]rest. Levels of mRNA for TNFa, IL-1b and
IL-6 were similar in wt and mdx myotubes, whereas iNOS expression was in-
creased 5-fold in mdx myotubes. Moreover, both NF-kB inhibition and [Ca2þ]
rest inhibitors reduced iNOS gene expression.We propose that NF-kB is constitutively active in mdxmyotubes, modulated by
increased [Ca2þ]rest and this condition can account for iNOS overexpression
in dystrophic myotubes. We hypothesize that the differences in NF-kB activity
may help to understand the mechanisms of muscle damage in DMD.
Fondecyt 1110467, FONDAP15010006 and AFM14562 (EJ). NIH AR43140,
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Skeletal muscle growth and development from embryo to adult consists of a se-
ries of carefully regulated changes in gene expression. In our previous tran-
scriptional profiling study [Sporer et al., BMC Genomics 12:143 (2011)], our
experiments using a turkey skeletal-muscle-specific oligonucleotide microarray
revealed that more than 3,000 genes were differentially expressed as a function
of three critical stages of muscle development: hyperplasia (18 d embryo), hy-
pertrophy (1 d post-hatch), and mature muscle (16 wk). The genes versican,
matrix Gla protein (MGP), and death-associated protein 1 (DAP1) were se-
lected for further study for their potential effects on modulation of muscle sat-
ellite cell proliferation and differentiation. Moreover, these genes exhibited
large fold-changes in expression as a function of muscle development in the
turkey. Small interfering RNA was used to knock down expression of these
genes during proliferation and differentiation of cultured turkey muscle satellite
cells; DNA content and creatine kinase activity were quantified as markers of
proliferation and differentiation, respectively. Knockdown of each of the genes
was associated with altered rates of proliferation and differentiation. Versican
and MGP predominantly affected proliferation, but later stages of differentia-
tion were also affected by the knockdown of versican and MGP. The knock-
down of DAP1 dramatically inhibited satellite cell differentiation to form
myotubes, with reduction in creatine kinase activity of up to 90% compared
to the control. Microarray and pathway analysis of the proliferating and differ-
entiating DAP1 knockdown cells indicated that several genes associated with
calcium signaling were differentially expressed. This is the first report that
these genes, with no previously documented functions in regulation of muscle
development, may play critical roles in muscle cell proliferation and
differentiation.Membrane Receptors & Signal Transduction I
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The human immunodeficiency virus (HIV) almost entirely depends on CCR5,
a host-encoded chemokine receptor member of the G protein-coupled receptor
(GPCR) superfamily, for infection of target cells and hence for transmission
from person to person. Inhibiting CCR5 is a viable strategy to prevent viral in-
fection since individuals expressing a truncated version of this protein are per-
fectly healthy. While native chemokines can display some weak anti-HIV
activity, it has been shown that N-terminally-modified analogues of the native
CCR5 ligand RANTES/CCL5 are much more potent inhibitors: analogues such
as PSC-RANTES, 6P4-RANTES, 5P12-RANTES, and 5P14-RANTES, have
potencies in the picomolar range.
PSC-RANTES owes its anti-HIV potency to its capacity to induce long-term
sequestration of CCR5 inside target cells. This molecule is a strong agonist
of CCR5 and activation of the receptor was believed to be required for internal-
ization.While some recombinant chemokines like 6P4-RANTES exhibit a com-
parable pharmacological profile to PSC-RANTES, others such as 5P12-
RANTES and 5P14-RANTES do not, which led us to conclude that anti-HIV
potency can be achieved by different mechanisms: 5P12-RANTES is capable
of efficiently blocking CCR5 without removing the receptor from the cell sur-
face and without activating it; 5P14-RANTES displays comparable anti-HIV
potency while causing only partial internalization in the absence of detectable
receptor activation.
Because CCR5 needs to be mobile in the cell membrane for HIV infection, we
investigated the effect of RANTES analogues on the diffusion dynamics and
spatial distribution of CCR5 in the cell membrane, using single-particle track-
ing and blink microscopy techniques in combination with quantum-dot or
